Walleye Trading LLC Mannkind Corp Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $193,384 - $275,633	48,958 New	48,958 $200,000
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $74,880 - $99,840	-48,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $45,120 - $106,080	48,000 New	48,000 $84,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $121,426 - $209,432	-111,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $126,995 - $250,650	111,400 New	111,400 $219,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.